在挪威研究人員進行的一項長期隨訪臨床研究中，涉及了大約500例患者的資料顯示：3.1％的患者患上了癲癇。這項研究結果在2005年8月期的《癲癇》雜志上進行了報道。

在研究中，重度腦卒中患者在腦卒中發作后，患上癲癇的風險比腦卒中程度較輕的患者要高出5倍。腦卒中發作后患上癲癇的風險，并不受到特定腦卒中治療機構治療方案、腦卒中起病年紀、或者地理區域的影響。對醫療工作人員而言，清醒認識到腦卒中發作后的風險是十分重要的。如果在腦卒中患者中檢查到癲癇發作，應當給予抗癲癇藥物治療，這樣通常可以有效地防止進一步地癲癇發作。

挪威國家癲癇中心教育與研究系主任Morten I. Lossius說：“開展進一步的研究探討新地治療方法，比如急性溶栓治療是否能夠減少腦卒中后地癲癇發作，是十分重要的。”正是該機構開展了這項研究。

Lossius醫生補充說：“改進腦卒中患者目前被認為金標準的治療方法同樣十分重要，除了溶栓治療之外，新型神經保護藥物與改進溶栓治療方法，在未來地治療中具有重要作用。”
Epilepsy Risk Found in Stroke Patients
 
A long follow-up study by researchers in Norway involving data from almost 500 patients has shown that 3.1% of stroke patients develop epilepsy. The finding was reported in the August 2005 issue of Epilepsia.

In the study, those patients who had severe strokes had five times the risk of developing epilepsy post-stroke compared to those with less-severe strokes. The risk of developing epilepsy after a stroke was not found to be influenced by treatment in a specialized stroke unit, age at onset of stroke, or geographical location. It is important for healthcare workers to be aware of this post-stroke risk. If they detect epileptic seizures in stroke patients, they can administer anti-epileptic drugs, which are often effective in preventing further seizures.

“It is important to perform further studies to find out whether newer treatments, such as acute thrombolysis can reduce the frequency of post-stroke epilepsy,” observed Morten I. Lossius, director of the department for education and research at the National Center for Epilepsy in Norway (Sandvika), which conducted the study.

“It is also important to try to improve the treatment of stroke patients beyond what today are known as the gold standards, which apart from thrombolysis, was followed in our study,” added Dr. Lossius. “New neuroprotective drugs and increased use of thrombolysis may play an important role in future treatment.”